Levels of Studied Biomarkers in Metastatic Prostate Cancer Patients
IAR Journal of Pharmacy · 09.08.2023 · 04 (02) · 1-4
DOI: 10.47310/iarjp.2023.v04i02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift IAR Journal of Pharmacy, online erschienen am 09.08.2023. Verfasst von Ali Zuhair Mahdi und 2 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Prostate cancer, a prevalent malignancy in males, often exhibits metastatic tendencies, particularly to bone. This study aimed to investigate the levels of selected biomarkers, including Alkaline Phosphatase (ALP) and serum lipid profile components, in metastatic prostate cancer patients. Blood samples were collected from male patients aged 50-70 with metastatic prostate cancer at Al-Furat Al-Awsat Oncology Hospital between 1/11/2021 and 15/1/2022. Biomarker levels were quantified using standardized assays. The results revealed elevated concentrations of ALP, total cholesterol, and triglycerides, accompanied by reduced levels of low-density lipoprotein (LDL) in the blood of metastatic prostate cancer patients compared to healthy controls. These findings underscore the potential role of these biomarkers in reflecting the pathophysiological changes associated with metastatic prostate cancer. The significance of these alterations in disease progression and potential implications for diagnostic and therapeutic strategies warrant further investigation
Zitieren
APA
Mahdi, A. Z., Jassim, M. M., & Hadi, S. M. (2023). Levels of Studied Biomarkers in Metastatic Prostate Cancer Patients. IAR Journal of Pharmacy, 04(02), 1-4. https://doi.org/10.47310/iarjp.2023.v04i02.001
Vancouver
Mahdi AZ, Jassim MM, Hadi SM. Levels of Studied Biomarkers in Metastatic Prostate Cancer Patients. IAR Journal of Pharmacy. 2023;04(02):1-4. doi:10.47310/iarjp.2023.v04i02.001
BibTeX
@article{Mahdi2023,
author = {Mahdi, Ali Zuhair and Jassim, Mustafa Mohammad and Hadi, Shahlaa Mahdi},
title = {Levels of Studied Biomarkers in Metastatic Prostate Cancer Patients},
journal = {IAR Journal of Pharmacy},
year = {2023},
volume = {04},
number = {02},
pages = {1--4},
doi = {10.47310/iarjp.2023.v04i02.001}
}
EUVIMED